Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Cariprazine in Bipolar I Disorder
NCT01059539Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Feb 2010
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of cariprazine in bipolar I disorder, sponsored by Forest Laboratories. Started Feb 2010; status: completed.
02
Drugs
cariprazine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01059539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059539.